These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18501510)

  • 21. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
    Maña P; Fordham SA; Staykova MA; Correcha M; Silva D; Willenborg DO; Liñares D
    J Neuroimmunol; 2009 May; 210(1-2):13-21. PubMed ID: 19344958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A preparative method of chronic experiment autoimmune encephalomyelitis].
    Yan JJ; Huang GX; Xiao B; Yang H; Wu ZG; Zhou WB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):663-8. PubMed ID: 18772503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.
    Liston A; Kohler RE; Townley S; Haylock-Jacobs S; Comerford I; Caon AC; Webster J; Harrison JM; Swann J; Clark-Lewis I; Korner H; McColl SR
    J Immunol; 2009 Mar; 182(5):3121-30. PubMed ID: 19234209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
    Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
    Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis.
    Moriya M; Nakatsuji Y; Miyamoto K; Okuno T; Kinoshita M; Kumanogoh A; Kusunoki S; Sakoda S
    Neurosci Lett; 2008 Aug; 440(3):323-6. PubMed ID: 18579300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis.
    Bennett JL; Blanchet MR; Zhao L; Zbytnuik L; Antignano F; Gold M; Kubes P; McNagny KM
    J Immunol; 2009 May; 182(9):5507-14. PubMed ID: 19380799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of water channel aquaporin-4 in experimental autoimmune encephalomyeritis.
    Miyamoto K; Nagaosa N; Motoyama M; Kataoka K; Kusunoki S
    J Neurol Sci; 2009 Jan; 276(1-2):103-7. PubMed ID: 18945445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis.
    Tafreshi AP; Ahmadi A; Ghaffarpur M; Mostafavi H; Rezaeizadeh H; Minaie B; Faghihzadeh S; Naseri M
    Phytother Res; 2008 Aug; 22(8):1083-6. PubMed ID: 18570265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
    Wang XS; Chen YY; Shang XF; Zhu ZG; Chen GQ; Han Z; Shao B; Yang HM; Xu HQ; Chen JF; Zheng RY
    Brain Res; 2009 Feb; 1253():198-209. PubMed ID: 19083996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
    Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
    J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
    Fezza F; De Simone C; Amadio D; Maccarrone M
    Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
    J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes.
    Battista N; Bari M; Tarditi A; Mariotti C; Bachoud-Lévi AC; Zuccato C; Finazzi-Agrò A; Genitrini S; Peschanski M; Di Donato S; Cattaneo E; Maccarrone M
    Neurobiol Dis; 2007 Jul; 27(1):108-16. PubMed ID: 17553686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement and demyelinating disease: no MAC needed?
    Barnum SR; Szalai AJ
    Brain Res Rev; 2006 Aug; 52(1):58-68. PubMed ID: 16443278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional disassociation of the central and peripheral fatty acid amide signaling systems.
    Cravatt BF; Saghatelian A; Hawkins EG; Clement AB; Bracey MH; Lichtman AH
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10821-6. PubMed ID: 15247426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetracosahexaenoylethanolamide, a novel
    Lin L; Metherel AH; Di Miceli M; Liu Z; Sahin C; Fioramonti X; Cummins CL; Layé S; Bazinet RP
    J Lipid Res; 2020 Nov; 61(11):1480-1490. PubMed ID: 32826272
    [No Abstract]   [Full Text] [Related]  

  • 40. Assignment of endogenous substrates to enzymes by global metabolite profiling.
    Saghatelian A; Trauger SA; Want EJ; Hawkins EG; Siuzdak G; Cravatt BF
    Biochemistry; 2004 Nov; 43(45):14332-9. PubMed ID: 15533037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.